Published October 26, 2017 | Version v1
Journal article

Benefit of salvage total pharyngolaryngoesophagectomy for recurrent locally advanced head and neck cancer after radiotherapy

  • 1. Department of Head and Neck Surgical Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, No 17 Panjiayuan Nanli, Chaoyang District, Head and Neck Ward 1, Beijing, 100021 (China)
  • 2. Department of Radiation Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing (China)
  • 3. Department of Otorhinolaryngology, Dalian Friendship Hospital, Dalian (China)

Description

The treatment modalities for recurrent locally advanced head and neck cancer failure after radiotherapy are limited with poor prognosis. Salvage supra-radical operation seems to be an option. It has not been established which patients will benefit from salvage total pharyngolaryngoesophagectomy. We retrospectively reviewed 66 patients with previously irradiated recurrent T4 head and neck cancer who underwent salvage total pharyngolaryngoesophagectomy at our institution between January 2001 and June 2014. The clinical outcome and toxicities were analyzed. Flap loss occurred in 2 patients, and the incidence of fistulas and anastomosis strictures was 15.6% (10/66) and 13.6% (9/66), respectively. The median survival time of the entire cohort was 12 months. The interval between radiation and salvage surgery, and microscopic carotid artery invasion were identified as independent prognostic factors for overall survival. The 3-year overall survival rates of patients with (n = 33) and without (n = 33) risk factors were 9.1% and 47.2%, respectively (p = 0.007). A time interval between radiation and salvage surgery ≤6 months and previous concurrent chemotherapy or targeted therapy were risk factors for severe post-operative complications. Salvage total pharyngolaryngoesophagectomy is beneficial to selected patients with recurrent locally advanced head and neck cancer after radiotherapy.

Availability note (English)

Available from http://dx.doi.org/10.1186/s13014-017-0900-2; Available from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5658928

Additional details

Identifiers

Publishing Information

Journal Title
Radiation Oncology (Online)
Journal Volume
12
Journal Page Range
vp.
ISSN
1748-717X

INIS

Country of Publication
United Kingdom
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
49082469
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
CAROTID ARTERIES; FACE; NECK; NEOPLASMS; PATIENTS; RADIATION HAZARDS; RADIOTHERAPY
Descriptors DEC
ARTERIES; BLOOD VESSELS; BODY; CARDIOVASCULAR SYSTEM; DISEASES; HAZARDS; HEAD; HEALTH HAZARDS; MEDICINE; NUCLEAR MEDICINE; ORGANS; RADIOLOGY; THERAPY

Optional Information

Copyright
Copyright (c) The Author(s). 2017
Notes
PMCID: PMC5658928; PMID: 29073917; PUBLISHER-ID: 900; OAI: oai:pubmedcentral.nih.gov:5658928